Walleye Capital LLC Regeneron Pharmaceuticals, Inc. Call Options Transaction History

Walleye Capital LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$883.2 - $1071.19 $5.3 Million - $6.43 Million	-6,000 Reduced 42.55%	8,100 $8.51 Million
Q1 2024 May 15, 2024	BUY	$902.69 - $993.35 $9.75 Million - $10.7 Million	10,800 Added 327.27%	14,100 $13.6 Million
Q4 2023 Feb 14, 2024	SELL	$775.18 - $881.7 $5.04 Million - $5.73 Million	-6,500 Reduced 66.33%	3,300 $2.9 Million
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $2.29 Million - $2.79 Million	3,300 Added 50.77%	9,800 $8.07 Million
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $70,003 - $83,035	100 Added 1.56%	6,500 $4.67 Million
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $4.15 Million - $5.04 Million	6,100 Added 2033.33%	6,400 $5.26 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $172,191 - $217,296	300 New	300 $207,000
Q4 2019 Feb 14, 2020	SELL	$274.13 - $376.51 $8.47 Million - $11.6 Million	-30,900 Reduced 87.29%	4,500 $1.69 Million
Q3 2019 Nov 14, 2019	BUY	$273.46 - $318.39 $6.67 Million - $7.77 Million	24,400 Added 221.82%	35,400 $9.82 Million
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $1.35 Million - $1.87 Million	4,500 Added 69.23%	11,000 $3.44 Million
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $2.42 Million - $2.86 Million	6,500 New	6,500 $2.67 Million

1,535

83.8M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.